Former Lundbeck Chief Executive Anders Gersel Pedersen, M.D., Ph.D, would like to have left as managing figure in the pharmaceutical company some time before he actually did.
Today, he's a professional member of the board with posts in, among others, biotechnology company Genmab and Bavarian Nordic. For more than a decade, however, he served as executive vice president and head of research and development at Lundbeck, a position he left in the beginning of 2019.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.